46.59 USD
-0.88 (-1.85%)
46.59 USD
0 (0%)
SNY gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. SNY has an excellent profitability rating, but there are concerns on its financial health. SNY has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year SNY was profitable.
- Each year in the past 5 years SNY has been profitable.
- In the past 5 years SNY always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 10.63%, SNY belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 18.84%, SNY belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
- The Return On Invested Capital of SNY (13.40%) is better than 93.23% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for SNY is significantly below the industry average of 12.84%.
- The last Return On Invested Capital (13.40%) for SNY is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROIC | 13.4% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
- With an excellent Profit Margin value of 20.63%, SNY belongs to the best of the industry, outperforming 91.15% of the companies in the same industry.
- SNY's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 23.61%, SNY belongs to the top of the industry, outperforming 90.63% of the companies in the same industry.
- SNY's Operating Margin has improved in the last couple of years.
- The Gross Margin of SNY (72.29%) is better than 79.69% of its industry peers.
- In the last couple of years the Gross Margin of SNY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
- SNY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for SNY remains at a similar level compared to 1 year ago.
- The number of shares outstanding for SNY remains at a similar level compared to 5 years ago.
- SNY has a better debt/assets ratio than last year.
2.2 Solvency
- A Debt/Equity ratio of 0.18 indicates that SNY is not too dependend on debt financing.
- SNY has a Debt to Equity ratio (0.18) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACC1.78
WACC7.54%
2.3 Liquidity
- SNY has a Current Ratio of 1.06. This is a normal value and indicates that SNY is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.06, SNY is doing worse than 83.85% of the companies in the same industry.
- SNY has a Quick Ratio of 1.06. This is a bad value and indicates that SNY is not financially healthy enough and could expect problems in meeting its short term obligations.
- SNY has a Quick ratio of 0.30. This is amonst the worse of the industry: SNY underperforms 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 |
3. Growth
3.1 Past
- SNY shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.35%.
- Measured over the past 5 years, SNY shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
- The Revenue has been growing slightly by 2.56% in the past year.
- The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
- SNY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.41% yearly.
- The Revenue is expected to grow by 4.47% on average over the next years.
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- SNY is valuated reasonably with a Price/Earnings ratio of 10.52.
- Compared to the rest of the industry, the Price/Earnings ratio of SNY indicates a rather cheap valuation: SNY is cheaper than 90.10% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, SNY is valued rather cheaply.
- A Price/Forward Earnings ratio of 9.40 indicates a reasonable valuation of SNY.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of SNY indicates a rather cheap valuation: SNY is cheaper than 88.54% of the companies listed in the same industry.
- SNY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.52 | ||
| Fwd PE | 9.4 |
4.2 Price Multiples
- SNY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SNY is cheaper than 96.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.69 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- SNY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.44
PEG (5Y)2.06
EPS Next 2Y5.23%
EPS Next 3Y5.91%
5. Dividend
5.1 Amount
- SNY has a Yearly Dividend Yield of 2.75%.
- Compared to an average industry Dividend Yield of 0.40, SNY pays a better dividend. On top of this SNY pays more dividend than 93.75% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, SNY pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.75% |
5.2 History
- The dividend of SNY has a limited annual growth rate of 4.30%.
- SNY has paid a dividend for at least 10 years, which is a reliable track record.
- SNY has decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.3%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- SNY pays out 34.36% of its income as dividend. This is a sustainable payout ratio.
- SNY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.36%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
46.59
-0.88 (-1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-24 2025-10-24/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners46.74%
Inst Owner Change0.07%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap113.17B
Revenue(TTM)66.91B
Net Income(TTM)13.80B
Analysts79.31
Price Target58.48 (25.52%)
Short Float %0.35%
Short Ratio3.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.75% |
Yearly Dividend2.21
Dividend Growth(5Y)4.3%
DP34.36%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.79%
Min EPS beat(2)-2.29%
Max EPS beat(2)5.86%
EPS beat(4)2
Avg EPS beat(4)1.85%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)5
Avg EPS beat(8)3.19%
EPS beat(12)7
Avg EPS beat(12)2.67%
EPS beat(16)11
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.95%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)3
Avg Revenue beat(12)8.5%
Revenue beat(16)7
Avg Revenue beat(16)20.74%
PT rev (1m)-6.02%
PT rev (3m)-8.28%
EPS NQ rev (1m)-3.33%
EPS NQ rev (3m)-10.04%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-2.01%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.52 | ||
| Fwd PE | 9.4 | ||
| P/S | 1.46 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.33 | ||
| P/tB | 22.16 | ||
| EV/EBITDA | 5.69 |
EPS(TTM)4.43
EY9.51%
EPS(NY)4.95
Fwd EY10.63%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32
BVpS35.04
TBVpS2.1
PEG (NY)4.44
PEG (5Y)2.06
Graham Number59.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.63% | ||
| ROE | 18.84% | ||
| ROCE | 16.17% | ||
| ROIC | 13.4% | ||
| ROICexc | 14.75% | ||
| ROICexgc | 65.74% | ||
| OM | 23.61% | ||
| PM (TTM) | 20.63% | ||
| GM | 72.29% | ||
| FCFM | N/A |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.68 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.06 | ||
| Quick Ratio | 0.3 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC7.54%
ROIC/WACC1.78
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y2.37%
EPS Next 2Y5.23%
EPS Next 3Y5.91%
EPS Next 5Y7.41%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year-0.09%
Revenue Next 2Y3.14%
Revenue Next 3Y4.36%
Revenue Next 5Y4.47%
EBIT growth 1Y9.12%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year29.1%
EBIT Next 3Y13.19%
EBIT Next 5Y10.5%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI-ADR / SNY FAQ
What is the fundamental rating for SNY stock?
ChartMill assigns a fundamental rating of 5 / 10 to SNY.
Can you provide the valuation status for SANOFI-ADR?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI-ADR (SNY). This can be considered as Fairly Valued.
How profitable is SANOFI-ADR (SNY) stock?
SANOFI-ADR (SNY) has a profitability rating of 8 / 10.
What are the PE and PB ratios of SANOFI-ADR (SNY) stock?
The Price/Earnings (PE) ratio for SANOFI-ADR (SNY) is 10.52 and the Price/Book (PB) ratio is 1.33.
How sustainable is the dividend of SANOFI-ADR (SNY) stock?
The dividend rating of SANOFI-ADR (SNY) is 8 / 10 and the dividend payout ratio is 34.36%.